You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ADVIL COLD AND SINUS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Advil Cold And Sinus, and what generic alternatives are available?

Advil Cold And Sinus is a drug marketed by Haleon Us Holdings and is included in two NDAs.

The generic ingredient in ADVIL COLD AND SINUS is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ADVIL COLD AND SINUS?
  • What are the global sales for ADVIL COLD AND SINUS?
  • What is Average Wholesale Price for ADVIL COLD AND SINUS?
Summary for ADVIL COLD AND SINUS
US Patents:0
Applicants:1
NDAs:2
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 2
Patent Applications: 2
What excipients (inactive ingredients) are in ADVIL COLD AND SINUS?ADVIL COLD AND SINUS excipients list
DailyMed Link:ADVIL COLD AND SINUS at DailyMed
Drug patent expirations by year for ADVIL COLD AND SINUS

US Patents and Regulatory Information for ADVIL COLD AND SINUS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Haleon Us Holdings ADVIL COLD AND SINUS ibuprofen; pseudoephedrine hydrochloride CAPSULE;ORAL 021374-001 May 30, 2002 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Haleon Us Holdings ADVIL COLD AND SINUS ibuprofen; pseudoephedrine hydrochloride TABLET;ORAL 019771-001 Sep 19, 1989 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ADVIL COLD AND SINUS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Haleon Us Holdings ADVIL COLD AND SINUS ibuprofen; pseudoephedrine hydrochloride CAPSULE;ORAL 021374-001 May 30, 2002 ⤷  Sign Up ⤷  Sign Up
Haleon Us Holdings ADVIL COLD AND SINUS ibuprofen; pseudoephedrine hydrochloride TABLET;ORAL 019771-001 Sep 19, 1989 ⤷  Sign Up ⤷  Sign Up
Haleon Us Holdings ADVIL COLD AND SINUS ibuprofen; pseudoephedrine hydrochloride CAPSULE;ORAL 021374-001 May 30, 2002 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ADVIL COLD AND SINUS

See the table below for patents covering ADVIL COLD AND SINUS around the world.

Country Patent Number Title Estimated Expiration
Japan H01503539 ⤷  Sign Up
Canada 1258430 MIXTURES CONTRE LA TOUX/LE RHUME CONTENANT DES MEDICAMENTS NON STEROIDIENS ANTI-INFLAMMATOIRES (COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI- INFLAMMATORY DRUGS) ⤷  Sign Up
South Africa 8802884 ⤷  Sign Up
Australia 1687388 ⤷  Sign Up
Japan H08157355 AMPHOTERIC PHARMACEUTICAL SOLUTION FOR SOFT GEL FILLING, TWO-PIECE CAPSULE SEALING OR TABLET MANUFACTURING ⤷  Sign Up
European Patent Office 0311677 MELANGES CONTRE LA TOUX/LE RHUME COMPRENANT DES REMEDES D'ANTIHISTAMINE NON SEDATIVE. (COUGH/COLD MIXTURES COMPRISING NON-SEDATING ANTIHISTAMINE DRUGS.) ⤷  Sign Up
South Korea 940006270 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.